Search

everythinglearnresearchcommunity

for

Search:↓

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Tofacitinib helped a woman regrow hair with no major side effects.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Centella asiatica extract may help promote hair growth by blocking a specific cell signaling pathway.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

A woman's hair turned white after taking a cancer drug called dasatinib.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Some blood pressure medications are linked to a higher risk of skin cancer.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Gefitinib can cause hair and eyebrow darkening.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.